- Home
- IAE vs EPIX Comparison
IAE vs EPIX Comparison
Compare IAE & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAE
- EPIX
- Stock Information
- Founded
- IAE 2007
- EPIX 2009
- Country
- IAE United States
- EPIX Canada
- Employees
- IAE N/A
- EPIX N/A
- Industry
- IAE Trusts Except Educational Religious and Charitable
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- IAE Finance
- EPIX Health Care
- Exchange
- IAE Nasdaq
- EPIX Nasdaq
- Market Cap
- IAE 64.2M
- EPIX 65.3M
- IPO Year
- IAE N/A
- EPIX N/A
- Fundamental
- Price
- IAE $5.90
- EPIX $1.79
- Analyst Decision
- IAE
- EPIX Hold
- Analyst Count
- IAE 0
- EPIX 3
- Target Price
- IAE N/A
- EPIX $2.00
- AVG Volume (30 Days)
- IAE 46.3K
- EPIX 186.2K
- Earning Date
- IAE 01-01-0001
- EPIX 05-13-2025
- Dividend Yield
- IAE 10.21%
- EPIX N/A
- EPS Growth
- IAE N/A
- EPIX N/A
- EPS
- IAE N/A
- EPIX N/A
- Revenue
- IAE N/A
- EPIX N/A
- Revenue This Year
- IAE N/A
- EPIX N/A
- Revenue Next Year
- IAE N/A
- EPIX N/A
- P/E Ratio
- IAE N/A
- EPIX N/A
- Revenue Growth
- IAE N/A
- EPIX N/A
- 52 Week Low
- IAE $5.31
- EPIX $1.40
- 52 Week High
- IAE $6.45
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- IAE 47.63
- EPIX 69.44
- Support Level
- IAE $5.79
- EPIX $1.42
- Resistance Level
- IAE $5.93
- EPIX $1.88
- Average True Range (ATR)
- IAE 0.14
- EPIX 0.10
- MACD
- IAE 0.01
- EPIX 0.03
- Stochastic Oscillator
- IAE 68.97
- EPIX 81.32
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.